Oral treatment of seborrhea with cysteamine derivatives

Claim 1

A method for treating a scalp, characterized by an excessive secretion of sebum, to improve the condition thereof by reducing said excessive secretion of sebum comprising orally administering to a human being having a scalp so characterized a therapeutic composition comprising an ingestible carrier admixed with a non-toxic active compound selected from the group consisting of: 2-phenylthio ethylamine dihydrogen phosphate, 2-p-t-butylphenylthio ethylamine trichloracetate, 2-p-methoxyphenylthio ethylamine ditartrate, 2-tolylthio ethylamine hydrobromide, 2-(1-biphenyl thio) ethylamine hydrochloride, 2-benzylthio 2-methyl propylamine hydrochloride, 2-benzylthio propylamine lactate, 2-o-aminophenylthio ethylamine succinate, 2-(2-naphthyl methylthio) ethylamine hydrochloride, 2-(2-naphthyl methylthio) ethylamine disuccinate, 2-o-chlorobenzylthio ethylamine hydrochloride, 2-p-chlorobenzylthio ethylamine glycolate, 2-o-fluorobenzylthio ethylamine hydrochloride, 2-β-phenylethylthio ethylamine glutamate, 2-diphenylmethylthio ethylamine hydrochloride, 2,4-dichloro 2-benzylthio ethylamine aspartate, 2-o-methoxy benzylthio ethylamine hydrochloride, 2-p-ethoxybenzylthio ethylamine hydrochloride, 2-p-bromobenzylthio ethylamine succinate, 2-(3,4-dimethoxy benzylthio) ethylamine malate, 2-(3,4,5-trimethoxy benzylthio) ethylamine hydrocinnamate, 2-p-methoxy benzylthio ethylamine salicylate, 2-o-methylbenzylthio ethylamine phenylacetate, 2-p-phenoxybenzylthio ethylamine hydrochloride, 2-benzylthio ethylamine panthothenate, 2-p-nitrobenzylthio ethylamine crotonate, 2-(1-naphthyl thio) ethylamine hydrochloride, 2-benzylthio propylamine and 2-benzylthio 2-methyl propylamine, said active compound being present in an amount ranging from 0.75 to 3 percent by weight of said composition and said composition being administered at a rate of 1.5-5 mg/kg/day based on the weight of the human being.

Claim 2

A method for treating a scalp, characterized by an excessive secretion of sebum, to improve the condition thereof by reducing said excessive secretion of sebum comprising orally administering to a human being having a scalp so characterized a therapeutic composition comprising an ingestible carrier admixed with a non-toxic active compound selected from the group consisting of: 2-phenylthio ethylamine dihydrogen phosphate, 2-p-t-butylphenylthio ethylamine trichloracetate, 2-p-methoxyphenylthio ethylamine ditartrate, 2-tolylthio ethylamine hydrobromide, 2-(1-biphenyl thio) ethylamine hydrochloride, 2-benzylthio 2-methyl propylamine hydrochloride, 2-benzylthio propylamine lactate, 2-o-aminophenylthio ethylamine succinate, 2-(2-naphthyl methylthio) ethylamine hydrochloride, 2-(2-naphthyl methylthio) ethylamine disuccinate, 2-o-chlorobenzylthio ethylamine hydrochloride, 2-p-chlorobenzylthio ethylamine glycolate, 2-o-fluorobenzylthio ethylamine hydrochloride, 2-β-phenylethylthio ethylamine glutamate, 2-diphenylmethylthio ethylamine hydrochloride, 2,4-dichloro 2-benzylthio ethylamine aspartate, 2-o-methoxy benzylthio ethylamine hydrochloride, 2-p-ethoxybenzylthio ethylamine hydrochloride, 2-p-bromobenzylthio ethylamine succinate, 2-(3,4-dimethoxy benzylthio) ethylamine malate, 2-(3,4,5-trimethoxy benzylthio) ethylamine hydrocinnamate, 2-p-methoxy benzylthio ethylamine salicylate, 2-o-methylbenzylthio ethylamine phenylacetate, 2-p-phenoxybenzylthio ethylamine hydrochloride, 2-benzylthio ethylamine panthothenate, 2-p-nitrobenzylthio ethylamine crotonate, 2-(1-naphthyl thio) ethylamine hydrochloride, 2-benzylthio propylamine and 2-benzylthio 2-methyl propylamine, said active compound being present in an amount ranging from 0.75 to 3 percent by weight of said composition and said composition being administered at a rate of 1.5-5 mg/kg/day based on the weight of the human being.